Skip to Main Content

Paper Details

Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson's disease.
Sci Adv
10
2022
CYLD, Deubiquitinase, PARIS, PARIS protein, PD, PGC, PGC-1, PINK1, Parkinson's disease, cylindromatosis, dopamine, dopamine neuron, dopaminergic neurodegeneration, mouse, parkin
Author NameAffiliation
Juan C TroncosoJohns Hopkins University School of Medicine
Juan C TroncosoJohns Hopkins University School of Medicine
Valina L DawsonInstitute for Cell Engineering, Johns Hopkins University School of Medicine
Valina L DawsonDiana Helis Henry Medical Research Foundation
Valina L DawsonAdrienne Helis Malvin Medical Research Foundation
Valina L DawsonJohns Hopkins University School of Medicine
Valina L DawsonJohns Hopkins University School of Medicine
Valina L DawsonJohns Hopkins University School of Medicine
Valina L DawsonInstitute for Cell Engineering, Johns Hopkins University School of Medicine
Valina L DawsonJohns Hopkins University School of Medicine
Valina L DawsonJohns Hopkins University School of Medicine
Valina L DawsonJohns Hopkins University School of Medicine
Valina L DawsonAdrienne Helis Malvin Medical Research Foundation
Valina L DawsonDiana Helis Henry Medical Research Foundation
Ted M DawsonInstitute for Cell Engineering, Johns Hopkins University School of Medicine
Ted M DawsonJohns Hopkins University School of Medicine
Ted M DawsonJohns Hopkins University School of Medicine
Ted M DawsonAdrienne Helis Malvin Medical Research Foundation
Ted M DawsonDiana Helis Henry Medical Research Foundation
Ted M DawsonJohns Hopkins University School of Medicine
Ted M DawsonInstitute for Cell Engineering, Johns Hopkins University School of Medicine
Ted M DawsonJohns Hopkins University School of Medicine
Ted M DawsonJohns Hopkins University School of Medicine
Ted M DawsonAdrienne Helis Malvin Medical Research Foundation
Ted M DawsonDiana Helis Henry Medical Research Foundation
Ted M DawsonJohns Hopkins University School of Medicine
  • 1 - 26

Datasets

Release 1.2